Today's Most Important Downgrades
Get Alerts VRNS Hot Sheet
Rating Summary:
17 Buy, 10 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 16 | Down: 17 | New: 5
Join SI Premium – FREE
Citi downgraded Varonis Systems (NASDAQ: VRNS) to Neutral from Buy with a price target of $21.00. Shares plunged more than 35% intra-day today following the company’s reported Q3 miss.
William Blair downgraded ABIOMED (NASDAQ: ABMD) to Market Perform from Outperform. Shares surged nearly 50% intra-day today after Johnson & Johnson (NYSE: JNJ) announced it had entered into a definitive agreement to acquire through a tender offer all outstanding shares of ABIOMED, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion.
KeyBanc downgraded Avista (NYSE: AVA) to Underweight from Sector Weight with a price target of $33.00 following the company’s reported below-consensus Q3 results and lowered guidance for 2022 and 2023. Shares were down more than 8% intra-day today.
Wedbush analyst Tom Nikic downgraded Steven Madden (NASDAQ: SHOO) to Neutral from Outperform and lowered its price target to $29.00 from $43.00.
By Davit Kirakosyan
Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Global Management (APO) to Buy US Silica (SLCA) for $15.50/sh Cash
- MGIC Investment (MTG) Announces $750M Share Buyback, Declares $0.115 Dividend
- Varonis at RSAC 2024: Reducing AI's Blast Radius and Deploying Copilots Safely
Create E-mail Alert Related Categories
Downgrades, Hot ListRelated Entities
William Blair, Citi, KeyBanc, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!